Lingual alveolar soft part sarcoma responsive to pazopanib: A case report

RATIONALE: The multi-targeted tyrosine kinase inhibitors such as cediranib, sunitinib and pazopanib have been reported to be effective for alveolar soft part sarcoma (ASPS). The efficacy of pazopanib for the patient with lingual ASPS has yet to be reported. PATIENT CONCERNS: A 23-year old man presen...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:Medicine (Baltimore)
Päätekijät: Yoshihiro, Tomoyasu, Tsuchihashi, Kenji, Nio, Kenta, Arita, Shuji, Nakano, Takafumi, Yasumatsu, Ryuji, Jiroumaru, Rina, Ariyama, Hiroshi, Kusaba, Hitoshi, Oda, Yoshinao, Akashi, Koichi, Baba, Eishi
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: Wolters Kluwer Health 2017
Aiheet:
5700
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC5682820/
https://ncbi.nlm.nih.gov/pubmed/29095301
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/MD.0000000000008470
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia